A study on the effectiveness of nicotine and counselling in tobacoo smoking cessation

Neetu Bala; Rekha Bansal; Parveen K. Sharma; Dinesh Kansal; Himani Prajapati

doi:10.18203/2319-2003.ijbcp20221041

Authors

Neetu Bala Department of Pharmacology, Dr. RPGMC Kangra, Tanda, Himachal Pradesh, India
Rekha Bansal Department of Pulmonary Medicine, Dr. RPGMC Kangra, Tanda, Himachal Pradesh, India
Parveen K. Sharma Department of Pharmacology, Dr. RPGMC Kangra, Tanda, Himachal Pradesh, India
Dinesh Kansal Department of Pharmacology, Dr. RPGMC Kangra, Tanda, Himachal Pradesh, India
Himani Prajapati Department of Pharmacology, Dr. RPGMC Kangra, Tanda, Himachal Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20221041

Keywords:

Counselling, Nicotine gums, Smoking cessation

Abstract

Background: Effectiveness of pharmacotherapy and counselling has been suggested by various research workers in smoking cessation, but studies show variable results with pharmacotherapy. Also efficacy of counselling and pharmacological intervention differs from centre to centre. So we conducted this study, to observe the role of counselling and nicotine gums in our setup.

Methods: 86 smokers willing to quit smoking were enrolled. Baseline counselling was provided at the time of enrolment, then at 1 week, 1 month, 3 months and at 6 months. Telephonic counselling was given to those who did not come for face to face counselling. Nicotine gums were prescribed for 3 months duration. At the end of 12 months, follow up outcome was measured.

Results: At 1 week 24% smokers, at 1 month 23%, at 3 months 12% and at 6 months 33% smokers attended face to face counselling session. At 1 week 66%, at 1 month 57%, at 3 months 63% and at 6 months 59% smokers received telephonic counselling. Nicotine gums were used by only 76% smokers. Out of those who used nicotine gums, only 3% used gums for 3 months duration and 97% stopped prematurely. Among those who used gums, 29% experienced side effects. Total 22 (26%) smokers stopped smoking at 12 months.

Conclusions: Less number of smokers coming for follow up counselling visits, suggest lack of motivation. Alternative counselling, like telephonic counselling, was much more accepted and was found to be helpful. Acceptance of nicotine gums was very less which also shows the lack of motivation. Abstinence rate of 26% shows that counselling and nicotine gums help in quitting smoking.

Metrics

Metrics Loading ...

Author Biography

Neetu Bala, Department of Pharmacology, Dr. RPGMC Kangra, Tanda, Himachal Pradesh, India

Pharmacology, senior resident

References

Tobacco: deadly in any form or disguise 2006. Available at: http://who.int/tobacco/communications/ 2006. Accessed on 18 March 2016.

Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. Cancer J Clin. 2005;55:281-99.

Delnevo CD, Pevzner ES, Hrywna M, Lewis MJ. Bidi cigarette use among young Adults in 15 States. Prevent Med. 2004;39:207-11.

Baska T, Madar R, Straka S. Non-pharmacological approach to smoking cessation. Bratis Lek Listy. 2001;102:570-4.

Benowitz NL. Nicotine Addiction. N Engl J Med. 2010;362:2295-303.

Global Adult Tobacco Survey (GATS). Available at: http://www.who.int/tobacco/surveillance/gats_india/en/index.html. Accessed on 12 March 2017.

Jha P, Chen Z. Poverty and chronic diseases in Asia: challenges and opportunities. CMAJ. 2007;177: 1059-62.

Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Treating tobacco use and dependence Clinical Practice Guideline. Available at: https://www.ahrq.gov/prevention/ guidelines/tobacco/index.html. Accessed on 12 March 2017.

Reddy KS, Gupta PC, editors. New Delhi, India: Ministry of Health and Family Welfare, Government of India; 2004. Indian experience with tobacco cessation. Report on tobacco control in India. Available at: http://mohfw.nic.in/WriteReadData/ l892s/911379183TobaccocontroinIndia_10Dec04.pdf. Accessed on 12 march 2017.

Kumar R, Kushwah AS, Mahakud GC, Prakash S, Vijayan VK. Smoking cessation interventions and continuous abstinence rate at one year. Indian J Chest Dis Allied Sci. 2007;49:201-7.

Varghese C, Kaur J, Desai NG, Murthy P, Malhotra S, Subbakrishna DK, et al. Initiating tobacco cessation services in India: challenges and opportunities. J Public Health. 2012;1:159-68.

Lancaster T, Stead LF. Cochrane Collaboration eds. UK: Oxford; 2000.

Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: US department of health and human services 2008. Available at: http//www.surgeon general.gov/tobacco/treating_tobacco_use08.pdf last. Accessed on 19 February 2017.

Benowitz NL, Jacob P, Savanapridi C. Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Therap. 1987;41:467-73.

Benowitz NL. Pharmacology of nicotine: Addiction and therapeutics. Annu Rev Pharmacol Toxicol. 1996;36:597-613.

Tonnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, Stockner M. Two and four mg nicotine chewing gum and group counselling in smoking cessation: an open, randomized, controlled trial with a 22 month follow- up. Addic Behav. 1988;13:17-27.

Kasza KA, Hyland AJ, Borland R. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2013;108:193-202.

West R, Zhou X. Is nicotine replacement therapy for smoking cessation effective in the “real world”? Findings from a prospective multinational cohort study. Thorax. 2007;62:998-1002.

Cummings KM, Fix B, Celestino P, Fix B, Celestino P, Carlin Menter S, et al. Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract. 2006;12:37-43.

Alpert HR, Connolly GN, Biener L. A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control. 2013;22:32-7.

Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA. 2002;288:1260-4.

Molyneux A, Lewis S, Leivers U, Anderton A, Antoniak M, Brackenride A, et al. Clinical trial comparing nicotine replacement therapy( NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax. 2003;58:484-8.

Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane System Rev. 2012.

High attrition rate US Department of Health Human Services. Women and smoking: a report of the surgeon general. Available at: https://www.hhs. gov/sites/default/files/2020-cessation-sgr-full-report.pdf. Accessed on 15 October 2021.

Lei Wu, Yao He, Bin Jiang, Fang Zuo, Quing hui Liu, Li Zhang et al Effectiveness of additional follow-up telephone counselling in a smoking cessation clinic in Beijing and predictors of quitting among Chinese male smokers. BMC Public Health. 2016;16:63.

Burns EK, Levinson AH. Discontinuation of nicotine replacement therapy among smoking-cessation attempters. Am J Prevent Med. 2008;34:212-5.

Cummings KM, Hyland A. Impact of nicotine replacement therapy on smoking behavior. Ann Rev Public Health. 2005;26:583-99.

Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2013;8:45-9.

Sheffer CE, Stitzer M, Brandon T, Bursac Z. Effectiveness of adding relapse prevention materials to telephone counseling. J Subst Abuse Treat. 2010;39:71-7.

Metz K, Flöter S, Kröger C, Donath C, Piontek D, Gradl S. Telephone booster sessions for optimizing smoking cessation for patients in rehabilitation

centers. Nicotine Tob Res. 2007;8:853-63.